07.31.2018 Issue 412

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

ICER Releases 'Reference Case'
for Economic Evaluations

Sunday, July 29

The Institute for Clinical and Economic Review released a “reference case” to detail the nonprofit’s approach to cost-effectiveness analysis.

Report Finds Rising Costs, Variable Coverage

Neuss: Progress Being Made in Higher-Value Cancer Care

Regeneron Takes Fight to Drug Pricing System

Experts: Drug Price Freezes Unlikely to Bring Lower Out-Of-Pocket Costs

Bill Would Allow Medicare to Negotiate Drug Prices

PRMA Consulting Offers Highlights of Meeting with Pricing Experts

Some Startups Looking to the Past for Modern Solutions

Proper Strategy Could Pave Path to Combining RCT, Real-World Data

Senior Principal - Health Economics

Principal - HTA

Principal, Health Economics

Principal, Pricing Market Access

Principal Epidemiology

Senior Health Economist

Real-World Evidence Project Coordinator – London, UK

Watson Health - Global Product Marketing Leader, Market Access

Industry Spotlight

Conferences Webinars
14th Annual Publication Planning
    August 14-15, Philadelphia, Pennsylvania

6th Annual Reimbursement and Access
    August 15-16, Philadelphia, Pennsylvania

World Congress on Biosensors and Bioelectronics
    August 20-21, Chicago, Illinois

340B Manufacturer Summit
    August 21-22, Washington, D.C.

Industry Perceptions and Expectations: The Role of ICER as an Independent HTA
    July 31

Partner With Patients to Achieve Value-Based Pricing
    August 2

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Biosimilars: U.S. Payer Perspectives

KAM Metrics: Driving Efficiency, Measuring Success

Biosimilars: E.U. Payer Perspectives

ICER’s Reference Case for Economic Evaluations: Principles and Rationale

A Guide to Getting Started in HEOR/Market Access Medical Writing

Impact of Displaying in-EHR Patient Drug Prices With or Without Patient Savings Messages

Taking a Total View: Linking Pharmacy + Medical Drug Trends

Reinventing Claims Payment for a Value-Based World

Special Thanks to Our Partners:
      Evidera   HealthCore     University of FL   Truven
      Xcenda    OM1    Parexel   Jefferson   Dymaxium
          Precision Xtract    Pharmerit    eMax Health   Sciformix
      Evidence Partners    ICON